Medication info
Donggu Jaltan Jeong 5/100 mg (Amlodipine Besilate, Losartan Potassium)

Donggu Jaltan Jeong 5/100 mg (Amlodipine Besilate, Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›100mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
Light pink rectangular film-coated tablet
Packaging
30 tablets per bottle
Approval status
Active

MFDS item code 201502700 · Approved 2015.04.30

Summary

Main use
Treatment of essential hypertension and Stage II hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using an individual component as follows, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should be based on factors such as baseline blood pressure, target blood pressure, and the expected degree of attainment of the treatment goal with the combination product compared with the individual products. Usually, this medicine is administered at 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: Administration of this medicine is not recommended in a small number of patients with reduced effective intravascular volume (e.g., patients being treated with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and Stage II hypertension

  • Essential hypertension
  • hypertension
View approved original text

This medication is used in patients with essential hypertension who do not achieve adequate blood pressure control with monotherapy using Amlodipine or Losartan. Moreover, it is used as an initial treatment for stage 2 hypertension patients who require combination therapy to reach the treatment goal blood pressure. That is, it is effective in controlling blood pressure in patients with essential hypertension and moderate hypertension who require combination treatment.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using an individual component as follows, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should be based on factors such as baseline blood pressure, target blood pressure, and the expected degree of attainment of the treatment goal with the combination product compared with the individual products. Usually, this medicine is administered at 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: Administration of this medicine is not recommended in a small number of patients with reduced effective intravascular volume (e.g., patients being treated with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Reduced amniotic fluid due to decreased fetal kidney function can lead to issues such as limb contractions or craniofacial deformities. Taking this medication during the early stages of pregnancy may also pose risks to the fetus; therefore, women of childbearing age should consult a physician before use. Patients with reduced intravascular volume, such as those on diuretics, should ensure normal fluid volume before taking this medication; otherwise, hypotension may occur. This medication should not be used in individuals allergic to active ingredients, pregnant or breastfeeding women, patients with severe liver dysfunction, patients with severe aortic stenosis, and patients in a state of shock. Patients undergoing blood tests or with impaired kidney function, patients on a strict sodium-restricted diet, and those with hyperkalemia should use this medication with caution. Taking this medication can cause symptoms such as dizziness or headaches, so caution is advised when driving or operating hazardous machinery. Patients with impaired liver or kidney function should have regular tests and adjust the dosage according to the doctor’s guidance. This medication may enhance the effect when taken with other antihypertensives, so consultation with a specialist is necessary when combining treatments. Especially, avoiding grapefruit juice is advised as it can excessively increase the medication's effectiveness. Risks to the fetus during pregnancy mean that it should be discussed with a doctor if planning a pregnancy or during pregnancy, and use during breastfeeding should be avoided. Safety in children or adolescents under 18 years of age has not been established, and its use is not recommended. Elderly patients, particularly those over 75 years of age, require proper dosage adjustment for this medication and should be guided by a physician during initial treatment. Overdosage can cause severe hypotension and heart problems, so strict adherence to dosage instructions is necessary, and medical attention should be sought immediately if adverse symptoms occur. This medication should be kept out of reach of children and should not be transferred to another container for safety.

Side effects

  • Dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • asthenia
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pit edema
Show 170 more
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • dizziness (vertigo)
  • conjunctival injection
  • frequent urination
  • fatigue
  • edema
  • vasculitis
  • hypertonia
  • sensory loss
  • paresthesia
  • peripheral neuropathy
  • syncope
  • altered taste
  • tremor
  • erectile dysfunction
  • gynecomastia
  • change in bowel habits
  • dry mouth
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased frequency of urination
  • urination disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • hypotension
  • sinus block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • skin erythema
  • maculopapular rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • diarrhea
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • edema
  • abdominal pain
  • angioedema
  • skin exfoliation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • hypotension
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory decline
  • decreased libido
  • memory impairment
  • migraine
  • neurogenic pain
  • panic disorder
  • sleep disorder
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • pulmonary congestion
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • photosensitivity
  • sweating
  • blurred vision
  • burning and pain in the eyes
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • visual impairment
  • nocturia
  • urethral infection
  • dry cough
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • liver function abnormalities
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • rhabdomyolysis
  • altered taste
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • ALT elevation
  • serum creatinine elevation
  • elevated liver enzymes
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactoid syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and humidity. It is also important to keep it at room temperature between 1 to 30 degrees Celsius, which will help maintain its efficacy and safety.

Appearance and packaging

Appearance

Light pink rectangular film-coated tablet

Package unit

30 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.